Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Faye Feller"'
Autor:
Mario González‐Sales, Ashley L. Lennox, Fei Huang, Chandra Pamulapati, Ying Wan, Libo Sun, Tymara Berry, Melissa Kelly Behrs, Faye Feller, Peter N. Morcos
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 13, Iss 7, Pp 1264-1277 (2024)
Abstract Imetelstat is a novel, first‐in‐class, oligonucleotide telomerase inhibitor in development for the treatment of hematologic malignancies including lower‐risk myelodysplastic syndromes and myelofibrosis. A nonlinear mixed‐effects mode
Externí odkaz:
https://doaj.org/article/36171795133f45eb9afd1a8df8925c30
Autor:
Valeria Santini, Uwe Platzbecker, Pierre Fenaux, Mikkael Sekeres, Michael Robert Savona, Yazan Madanat, María Díez Campelo, David Valcárcel, Thomas Illmer, Anna Jonášová, Petra Belohlavkova, Laurie Sherman, Tymara Berry, Souria Dougherty, Sheetal Shah, Qi Xia, Lixian Peng, Libo Sun, Ying Wan, Fei Huang, Annat Ikin, Shyamala Navada, Faye Feller, Amer M. Zeidan, Rami S. Komrokji
Publikováno v:
HemaSphere, Vol 7, p e5257893 (2023)
Externí odkaz:
https://doaj.org/article/d61229cd057144009a4659ae7cc4fc3f
Autor:
Mikkael Sekeres, Valeria Santini, María Díez Campelo, Rami S. Komrokji, Pierre Fenaux, Michael Robert Savona, Yazan Madanat, David Valcárcel, Thomas Illmer, Anna Jonášová, Petra Belohlavkova, Antoine Regnault, Kristin Creel, Nishan Sengupta, Laurie Sherman, Tymara Berry, Souria Dougherty, Sheetal Shah, Libo Sun, Ying Wan, Fei Huang, Annat Ikin, Shyamala Navada, Faye Feller, Amer M. Zeidan, Uwe Platzbecker
Publikováno v:
HemaSphere, Vol 7, p e5903029 (2023)
Externí odkaz:
https://doaj.org/article/bc2fc172079a4ae088c6cead3ea4e7fc
Autor:
John Mascarenhas, Claire Harrison, Jean-Jacques Kiladjian, Rami S. Komrokji, Steffen Koschmieder, Alessandro M. Vannucchi, Tymara Berry, Denise Redding, Laurie Sherman, Souria Dougherty, Lixian Peng, Libo Sun, Fei Huang, Ying Wan, Faye Feller, Srdan Verstovsek
Publikováno v:
Blood. 140:6826-6829
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05b45c4cdad5448742c798b15ec4cb68
https://doi.org/10.1182/blood-2022-160364
https://doi.org/10.1182/blood-2022-160364
Autor:
Uwe Platzbecker, Rami S. Komrokji, Pierre Fenaux, Amer M. Zeidan, Mikkael A. Sekeres, Michael Robert Savona, Yazan F. Madanat, Valeria Santini, Koen Van Eygen, Azra Raza, Ulrich Germing, Tymara Berry, Souria Dougherty, Sheetal Shah, Libo Sun, Fei Huang, Faye Feller, Ying Wan, Annat Ikin, Laurie Sherman
Publikováno v:
Blood. 140:1106-1108
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d4dbf3061b90be898fd646750d3b205
https://doi.org/10.1182/blood-2022-169050
https://doi.org/10.1182/blood-2022-169050
Autor:
Eugene Zhu, Qi Xia, Libo Sun, John Mascarenhas, Ying Wan, Rami S. Komrokji, Julia Wang, Alessandro M. Vannucchi, Jacqueline Bussolari, Faye Feller, Jean-Jacques Kiladjian, Aleksandra Rizo, Andrew T. Kuykendall
Publikováno v:
Annals of Hematology. 101:139-146
In the MYF2001 trial, treatment of Janus kinase (JAK) inhibitor-relapsed/refractory intermediate-2 or high-risk myelofibrosis (MF) with imetelstat 9.4 mg/kg every 3 weeks demonstrated encouraging median overall survival of 29.9 months. To provide his
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a20c00ca26c0d4a474b98a4025280a89
https://doi.org/10.1007/s00277-021-04683-w
https://doi.org/10.1007/s00277-021-04683-w
Autor:
Terrence Bradley, Andrew Kuykendall, Rami S. Komrokji, Tymara Berry, Souria Dougherty, Laurie Sherman, Lixian Peng, Fei Huang, Ying Wan, Faye Feller, John Mascarenhas
Publikováno v:
Blood. 140:3941-3942
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1f93630d8f0cca4bf52ec8ad17ba29c
https://doi.org/10.1182/blood-2022-159614
https://doi.org/10.1182/blood-2022-159614
Autor:
Alec W. Stranahan, Iryna Berezniuk, Sohini Chakraborty, Faye Feller, Mona Khalaj, Christopher Y. Park
Publikováno v:
Leukemia. 36(6)
Acute myeloid leukemia (AML) is characterized by poor clinical outcomes due to high rates of relapse following standard-of-care induction chemotherapy. While many pathogenic drivers have been described in AML, our understanding of the molecular mecha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::361cacd40c6ae7f9f53ad4987c4d22b6
https://pubmed.ncbi.nlm.nih.gov/35461365
https://pubmed.ncbi.nlm.nih.gov/35461365
Autor:
Eugene Zhu, Maria R. Baer, Dietger Niederwieser, Olatoyosi Odenike, Souria Dougherty, Laurie Sherman, Libo Sun, John Mascarenhas, Aleksandra Rizo, Fei Huang, Rami S. Komrokji, Bart L. Scott, Jean-Jacques Kiladjian, Alessandro M. Vannucchi, Bruno Martino, Francesca Palandri, Ying Wan, Jacqueline Bussolari, Ronald Hoffman, Faye Feller, Andreas Reiter, Esther Rose
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39(26)
PURPOSE Patients with myelofibrosis who are relapsed or refractory (R/R) to Janus-associated kinase inhibitors (JAKis) have poor clinical outcomes including dismal overall survival (OS) that ranges between 13 and 16 months. Imetelstat, a telomerase i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e652d4947d861536df008fab3efd7dd
https://pubmed.ncbi.nlm.nih.gov/34138638
https://pubmed.ncbi.nlm.nih.gov/34138638
Autor:
David P. Steensma, Sylvain Thepot, Valeria Santini, Souria Dougherty, Esther Rose, Edo Vellenga, Uwe Platzbecker, Jacqueline Bussolari, Patricia Font, Aleksandra Rizo, Mrinal M. Patnaik, Libo Sun, Fei Huang, Ying Wan, María Díez-Campelo, Koen Van Eygen, Laurie Sherman, Pierre Fenaux, Jun Ho Jang, Helen Varsos, Azra Raza, Faye Feller, Ulrich Germing
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(1), 48-+. AMER SOC CLINICAL ONCOLOGY
PURPOSE Patients with lower-risk (LR) myelodysplastic syndromes (MDS) who are RBC transfusion dependent and have experienced relapse after or are refractory to erythropoiesis-stimulating agent (ESA) have limited treatment options. High telomerase act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e59bb98394daa5ee0eb56572a542023a
https://pubmed.ncbi.nlm.nih.gov/33275487
https://pubmed.ncbi.nlm.nih.gov/33275487